National Medical Care Co. · TADAWUL:4005
National Medical Care — 1H 2025 Earnings Presentation
19 slides from National Medical Care's earnings presentation, Aug 5, 2025
Slide 1: Earnings Presentation 1H 2025
Earnings Presentation 1H 2025 5 August 2025 | Riyadh, KSA
Slide 2: Performance Highlights and Strategy
Performance Highlights and Strategy Care Medical Earnings Presentation – 5/8/25 2
Slide 3: Operating and Financial Performance Highlights
Operating and Financial Performance Highlights Strong financial and operational performance in the first half of the year supported by remarkable second quarter results Revenue 1H 2025 783 460.3 Total patients 1H 2025 New facility with significant strategic upside 783 SAR mn thousand +40% year-on-ye
Slide 4: Strategic Focus: Expansion, New Services, Efficiency, and Automation
Strategic Focus: Expansion, New Services, Efficiency, and Automation Overview of strategic initiatives New Services Home Healthcare Services Executive Health Check ReLib Mental Health Center Started Home Healthcare Services to increase patient Launched executive health check to raise cash Introduced
Slide 5: Operating and Financial Performance
Operating and Financial Performance 1H 2025 Care Medical Earnings Presentation – 5/8/25 5
Slide 6: Operational Trends
Operational Trends Higher patient numbers supported by robust organic growth at Care Medical’s more established facilities coupled with the successful integration of Al Salam hospital Operational Highlights1,2 Inpatients Admissions Quarterly Trend SAR mn 1H2025 1H2024 YoY, % 1H2025 LfL YoY, % (Admis
Slide 7: Income Statement
Income Statement Company-wide efficiency efforts led to improved gross and EBITDA margins in the first half of 2025. Lower NPM reflects high base effect from a one-off Zakat provision reversal that inflated net profit figures in 1H 2024. Income Statement Highlights Net Profit Development SAR mn 2Q20
Slide 8: Revenue Trends
Revenue Trends Top-line growth in 1H 2025 was supported by higher revenue from GOSI referrals, contributions from Al Salam hospital, and the ramp up of the Prince Sultan Military Medical City contract Revenue Development1 Revenue by Business Unit (1H 2025) (SAR mn) (%) AlBalad branch, 6.8% Haram bra
Slide 9: Costs Overview
Costs Overview Higher cost of revenues attributable to increased salaries as newly acquired facilities ramp-up operations and a rise in medicines and consumables outlays as surgical procedures continued to rise in 1H 2025 Total Expenses Breakdown (1H 2025) Cost of Revenues Breakdown (1H 2025) (%) (%
Slide 10: Balance Sheet Highlights
Balance Sheet Highlights Strong balance sheet supported by a solid cash reserves Balance Sheet Highlights Cash Conversion Cycle1 Trend SAR mn 2Q2025 4Q2024 YtD, % (Days) Total Non-Current Assets 1,269 1,273 -0% -19% Total Current Assets 1,268 1,229 +3% Total Assets 2,537 2,502 +1% Total Shareholders
Slide 11: Receivables Management
Receivables Management Rising receivables reflect rising revenues versus the previous year Trade Receivables1 Development Trade Receivables1 Structure (end of 2Q 2025) (SAR mn) (SAR mn) 34.6% Insurance 33.0% +16% MoH & Govt 23.4% 81 2 0 1,080 GOSI 4.8% Other 69 4.3% Cash 934 (7) Trade Receivables1 A
Slide 12: Cash Flow Highlights
Cash Flow Highlights Cash flow from operations supported by stronger results and a significant reduction in Zakat, finance income, and end-of-service benefits Cash Flow Highlights Cash Flow From Operations Development (SAR mn) SAR mn 2Q2025 2Q2024 YoY, % 1H2025 1H2024 YoY, % N/A Net Profit before za
Slide 13: Q&A Session
Q&A Session Care Medical Earnings Presentation – 5/8/25 13
Slide 14: Appendix
Appendix Care Medical Earnings Presentation – 5/8/25 14
Slide 15: Operating Performance Overview (1/2)
Operating Performance Overview1 (1/2) Total Patients Trend Surgeries Trend (Thousand patients) (Thousand surgeries) +20% CAGR +11% CAGR 639 742 651 55 532 19 19 20 254 253 261 362 193 16 13 136 339 385 398 427 227 FY20 +47% FY21 +20% FY22 +2% FY23 +14% FY24 FY20 +20% FY21 +19% FY22 +1% FY23 +7% FY24
Slide 16: Operating Performance Overview (2/2)
Operating Performance Overview1 (2/2) Bed Capacity Trend Bed Occupancy Trend (Available beds) (%) +15% CAGR 80.3% 79.2% 1,128 77.6% 349 655 655 655 655 70.8% 459 68.1% 335 335 335 335 320 320 320 320 320 FY20 +0% FY21 +0% FY22 +0% FY23 +72% FY24 FY20 FY21 FY22 FY23 FY24 Rawabi branch Malaz branch Ot
Slide 17: Financial Performance Overview
Financial Performance Overview Total Revenue Trend EBITDA Trend (SAR mn) (SAR mn) +12% CAGR +20% CAGR 377 1,294 1,082 302 809 845 918 243 214 179 FY20 +5% FY21 +9% FY22 +18% FY23 +20% FY24 FY20 +19% FY21 +13% FY22 +24% FY23 +25% FY24 Net Profit Trend Margins Trend (SAR mn) (%) 35.1% +32% CAGR 29.2%
Slide 18: Contacts
Contacts Institutional investor contact Alia Balbaa Investor Relations Director abalbaa@care.med.sa +966-11-418-4488 ext. 322 Investor Relations website https://ir.care.med.sa/ Care Medical Earnings Presentation – 5/8/25 18
Slide 19: Disclaimer
Disclaimer All information included in this document is for general use only and has not been independently verified, nor does it constitute or form part of any invitation or inducement to engage in any investment activity, nor does it constitute an offer or invitation or recommendation to buy or su
National Medical Care Company (Care Medical) — 1H 2025 Earnings Presentation on 6ix